|
|
|
Tobacco Smoking Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Smoking.
Please click "Search" to find Smoking clinical trials and medical research studies or read below for information on Smoking diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 31 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-06105
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Hartford, CT
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-15213
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Pittsburgh, PA
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-19335
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Downington, PA
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-26505
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Morgantown, WV
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-28207
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Charlotte, NC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-29303
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Spartanburg, SC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-29340
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Gaffney, SC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-29379
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Union, SC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-29406
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Charleston, SC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-29615
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Greenville, SC
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-35294
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Birmingham, AL
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-35501
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Jasper, AL
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-35630
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Florence, AL
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-36608
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Mobile, AL
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-37601
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Johnson City, TN
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-55407
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Minneapolis, MN
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-63017
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Chesterfield, MO
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-63141
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: St. Louis, MO
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-63301
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: St. Charles, MO
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-70584
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Sunset, LA
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-83814
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Coeur D'Alene, ID
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-85006
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Phoenix, AZ
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-90505
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Torrance, CA
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-92103
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: San Diego, CA
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - NCT00857766-99204
Conditions: Cardiovascular Disease - Chronic Bronchitis - Chronic Obstructive Pulmonary Disease (COPD) - CV Risk - Emphysema - Smoking Location: Spokane, WA
- A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control - NCT00830739-21224
Conditions: Tobacco Use Disorder - Nicotine Dependence Location: Baltimore, MD
- A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence - NCT01011907-94608
Conditions: Smoking and Alcohol Abuse Location: Emeryville, CA
- A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation - NCT01102114-
Conditions: Smoking Cessation Location: Charleston, WV
- A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers - NCT00924768-27599
Conditions: Healthy - Cigarette Smoking Location: Chapel Hill, NC
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02114
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Boston, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-02130
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Jamaica Plain, MA
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-03063
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Nashua, NH
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-49503
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Grand Rapids, MI
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia - NCT00621777-55454
Conditions: Schizophrenia - Schizoaffective Disorder - Smoking Location: Minneapolis, MN
- A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs) - NCT01106638-10467
Conditions: Smoking - HIV Infections - AIDS Location: Bronx, NY
- ADHD Smoking Cessation Study - NCT00736255-27705
Conditions: Attention Deficit Hyperactivity Disorder - Nicotine Dependence Location: Durham, NC
- Affect Regulation Training for Pregnant Smokers - NCT01163864-14203
Conditions: Smoking Cessation Location: Buffalo, NY
- Alcohol Counseling for Telephone Quitline Callers - NCT01120080-14263
Conditions: Smoking - Nicotine Dependence - Alcohol Dependence Location: Buffalo, NY
- An Alternative Dosing Schedule of Varenicline for Smoking Cessation - NCT00835900-14263
Conditions: Smoking Cessation Location: Buffalo, NY
- Anxiety Sensitivity Program for Smoking Cessation - NCT00387049-05405
Conditions: Smoking Cessation Location: Burlington, VT
- Assessment of a Teachable Moment for Smoking Cessation - NCT00596440-19104
Conditions: Nicotine Dependence Location: Philadelphia, PA
- Behavioral Exercise Intervention for Smoking Cessation - NCT00713063-02906
Conditions: Nicotine Dependence Location: Providence, RI
- Biomarkers of Molecular Risk in Smokers - NCT00598143-10065
Conditions: Smoking Cessation Location: New York, NY
- Brain Activity, Genes, and Smoking - NCT00915798-92612
Conditions: Smoking - Abstinence Location: Irvine, CA
- Brief Voluntary Alcohol and Drug Intervention for Middle School Youth - NCT01081119-
Conditions: Alcohol Drinking - Cigarette Smoking - Marijuana Smoking Location: Los Angeles, CA
- Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking - NCT00664261-02114
Conditions: Health Status Unknown Location: Boston, MA
- Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain - NCT01091090-55905
Conditions: Smoking Cessation Location: Rochester, MN
- College Students and Smoking Cessation - NCT00941395-77004
Conditions: Smoking Cessation - Habits - Smoking Location: Houston, TX
- College Students and Smoking Cessation - NCT00941395-77843
Conditions: Smoking Cessation - Habits - Smoking Location: College Station, TX
- Combined Treatment for Tobacco and Alcohol Use in Puerto Rico - NCT00570804-77030
Conditions: Smoking Location: Houston, TX
- Combining Varenicline and Bupropion for Smoking Cessation - NCT00943618-77030
Conditions: Smoking Cessation Location: Houston, TX
- Comparison of Hookah and Cigarette Smoking - NCT00992550-94131
Conditions: Smoking Location: San Francisco, CA
- Comparison of Low Yield Cigarettes in African Americans vs. Whites - NCT01058876-94101
Conditions: Cigarette Smoking Location: San Francisco, CA
- Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration - NCT01115231-29401
Conditions: Macular Degeneration Location: Charleston, SC
- Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes - NCT00865553-05405
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder Location: Burlington, VT
- Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk - NCT00861146-06111
Conditions: Tobacco Use Cessation - Alcohol-Related Disorders Location: Newington, CT
- Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk - NCT00861146-06516
Conditions: Tobacco Use Cessation - Alcohol-Related Disorders Location: West Haven, CT
- Contingency Management for Smoking Abstinence With Adolescent Smokers - NCT01056588-43205
Conditions: Cigarette Smoking Location: Columbus, OH
- Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders - NCT00508560-98109
Conditions: Nicotine Dependence - Psychotic Disorders Location: Seattle, WA
- Contingency Management for Smoking in Substance Abusers - NCT00807742-02903
Conditions: Substance Abuse Location: Providence, RI
- Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia - NCT00136760-02912
Conditions: Schizophrenia and Disorders With Psychotic Features - Tobacco Use Disorder Location: Providence, RI
- Coping Skills Treatment for Smoking Cessation - NCT01061528-02906
Conditions: Nicotine Dependence Location: Providence, RI
- Cue Reactivity in Virtual Reality: The Role of Context - NCT00862927-77030
Conditions: Smoking Location: Houston, TX
- Determinants of Smoking Cessation Among Latinos - NCT01008748-77030
Conditions: Smoking Cessation Location: Houston, TX
- Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy - NCT00699556-06519
Conditions: Alcohol Drinking Location: New Haven, CT
- Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking? - NCT00580645-06519
Conditions: Alcohol Drinking Location: New Haven, CT
- Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence - NCT01038414-02115
Conditions: Tobacco Addiction Location: Boston, MA
- Dynamic Assessment and Referral System - Evaluation - NCT01153373-01655
Conditions: Smoking - Alcohol Abuse - Drug Abuse Location: Worcester, MA
- Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence - NCT00304707-01730
Conditions: Smoking Cessation - Alcohol-Related Disorders Location: Bedford, MA
- Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers - NCT00341432-
Conditions: Smoking - Pregnancy Location: Washington, DC
- Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers - NCT00341432-20037
Conditions: Smoking - Pregnancy Location: Washington, DC
- Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia - NCT00435370-77030
Conditions: Smoking Cessation - Schizophrenia Location: Houston, TX
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent Smokers - NCT01148355-21224
Conditions: Nicotine Dependence Location: Baltimore, MD
- Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia - NCT00770237-21228
Conditions: Schizophrenia - Nicotine Dependence Location: Catonsville, MD
- Effects of Smoking on Opioid Receptor Binding: A PET Study - NCT00618631-21224
Conditions: Substance-related Discorder Location: Baltimore, MD
- Effects of Smoking on Opioid Receptor Binding: A PET Study - NCT00618631-21287
Conditions: Substance-related Discorder Location: Baltimore, MD
- Efficacy of Losartan in Preventing Progression of COPD - NCT00720226-21205
Conditions: COPD - Emphysema - Chronic Bronchitis - Smoking Location: Baltimore, MD
- Efficacy of Tobacco Quitline for Cancer Survivors - NCT00827866-38105
Conditions: Smoking Cessation Location: Memphis, TN
- En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking - NCT01040949-27705
Conditions: Smoking Cessation Location: Durham, NC
- Enhancing a High School Based Smoking Cessation Program - NCT01145001-06519
Conditions: Nicotine Dependence Location: New Haven, CT
- Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness - NCT00500695-08901
Conditions: Schizophrenia - Schizoaffective Disorder Location: New Brunswick, NJ
- Evaluating a Telemedicine Smoking Cessation Program in Rural Primary Care Practices - NCT00843505-66160
Conditions: Smoking Location: Kansas City, KS
- Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study) - NCT00632411-38105
Conditions: Smoking - Smoking Cessation Location: Memphis, TN
- Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study) - NCT00632411-78236
Conditions: Smoking - Smoking Cessation Location: Lackland AFB, TX
- Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women - NCT00632476-97266
Conditions: Pregnancy - Smoking Location: Portland, OR
- Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype - NCT00894166-
Conditions: Smoking Cessation Location: Charlotte, Durham, Raleigh, Wi, NC
- Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy - NCT00224185-10021
Conditions: Smoking - Lung Diseases Location: New York, NY
- Evaluation of Treatments to Improve Smoking Cessation Medication Adherence - NCT01120704-53711
Conditions: Smoking - Smoking Cessation - Adherence - Nicotine - Motivation Location: Madison, WI
- Examining a Text Message Intervention for Smoking Cessation - NCT01166464-02903
Conditions: Tobacco Use Disorder - Nicotine Dependence Location: Providence, RI
- Exercise or Relaxation for Smoking Cessation - NCT00921388-06030
Conditions: Nicotine Dependence - Smoking Cessation Location: Farmington, CT
- Exercise or Relaxation for Smoking Cessation - NCT00921388-55455
Conditions: Nicotine Dependence - Smoking Cessation Location: Minneapolis, MN
- Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta - NCT00181792-02138
Conditions: ADHD - Smoking Location: Cambridge, MA
- Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal - NCT00664404-77030
Conditions: Smoking Location: Houston, TX
- Genetic Risk Factors for Lung Cancer in Non-Smoking Women in Xuan Wei and Fu Yuan Counties in Yun Nan Province, China - NCT00341926-20892
Conditions: Lung Cancer Location: Bethesda, MD
- Group Therapy for Nicotine Dependence - NCT00297479-77230
Conditions: Smoking - Tobacco Use Cessation Location: Houston, TX
- Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking - NCT00666978-64130
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder Location: Kansas City, MO
- Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking - NCT00666978-66160
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder Location: Kansas City, KS
- Healthier Hearts and Brains in Treating Smoking: The HABITS Study - NCT00581464-15213
Conditions: Smoking Location: Pittsburgh, PA
- Hygienists Internet Quality Improvement in Tobacco Cessation (HiQuit) - NCT01108432-
Conditions: Smoking Cessation Location: Minneapolis, MN
- Hygienists Internet Quality Improvement in Tobacco Cessation (HiQuit) - NCT01108432-35294
Conditions: Smoking Cessation Location: Birmingham, AL
- Identifying Optimal Smoking Cessation Intervention Components (Cessation) - NCT01116986-53711
Conditions: Smoking - Smoking Cessation - Nicotine Location: Madison, WI
- Identifying Treatments to Motivate Smokers to Quit - NCT01122238-53711
Conditions: Smoking - Smoking Cessation - Motivation - Nicotine Location: Madison, WI
- Impact of Smoking Cessation on Sleep - 5 - NCT00132821-94025
Conditions: Tobacco Use Cessation - Sleep Disorders Location: Menlo Park, CA
- Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans - NCT00816036-52246
Conditions: Cigarette Smoking Location: Iowa City, IA
- Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans - NCT00816036-55417
Conditions: Cigarette Smoking Location: Minneapolis, MN
- Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans - NCT00816036-68105
Conditions: Cigarette Smoking Location: Omaha, NE
- Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans - NCT00816036-80220
Conditions: Cigarette Smoking Location: Denver, CO
- Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines - NCT01087905-53711
Conditions: Smoking - Smoking Cessation Location: Madison, WI
- Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines - NCT01087905-98104
Conditions: Smoking - Smoking Cessation Location: Seattle, WA
- Incentive-Based Smoking Cessation for Methadone Patients - NCT00718835-05401
Conditions: Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence Location: Burlington, VT
- Innovative Interventions for Smoking Cessation - NCT01050569-55414
Conditions: Nicotine Addiction Location: Minneapolis, MN
- Insulin Resistance in Smokers Undergoing Smoking Cessation - NCT00877513-90059
Conditions: Cardiovascular Disease - Insulin Resistance Location: Los Angeles, CA
- Internet Stop Smoking Study - Phase VI - NCT00721786-94110
Conditions: Smoking Location: San Francisco, CA
- Internet-based Group Contingency Management to Promote Smoking Abstinence - NCT01181661-10010
Conditions: Cigarette Smoking Location: New York City, NY
- Internet-based Group Contingency Management to Promote Smoking Abstinence - NCT01181661-32611
Conditions: Cigarette Smoking Location: Gainesville, FL
- Internet-Based Smoking Cessation for Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans - NCT01001546-27705
Conditions: Smoking Cessation Location: Durham, NC
- Investigation of Cycloserine as a Smoking Cessation Treatment - NCT01062932-77030
Conditions: Nicotine Addiction Location: Houston, TX
- Literacy and Smoking Risk Communications - NCT00684437-77030
Conditions: Smoking Location: Houston, TX
- Longitudinal Care: Smoking Reduction to Aid Cessation - NCT00309296-55417
Conditions: Chronic Diseases Location: Minneapolis, MN
- Low-Cost Contingency Management for Smoking Cessation - NCT01040260-94121
Conditions: Tobacco Use Cessation Location: San Francisco, CA
- Maintaining Nonsmoking - NCT01162239-94143
Conditions: Nicotine Dependence Location: San Francisco, CA
- Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder - NCT00382915-08901
Conditions: Schizophrenia - Bipolar Disorder Location: New Brunswick, NJ
- Measuring Smoking Behaviors While Using Varenicline - NCT00948155-19104
Conditions: Nicotine Dependence Location: Philadelphia, PA
- Media Literacy to Prevent Adolescent Smoking - NCT00398190-15132
Conditions: Smoking Status Location: McKeesport, PA
- Media Literacy to Prevent Adolescent Smoking - NCT00398190-15210
Conditions: Smoking Status Location: Pittsburgh, PA
- Media Literacy to Prevent Adolescent Smoking - NCT00398190-15213
Conditions: Smoking Status Location: Pittsburgh, PA
- Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence - NCT00916721-02114
Conditions: Smoking Cessation Location: Boston, MA
- Menominee Stop Tobacco Abuse Renew Tradition Study - NCT01083654-54135
Conditions: Smoking Location: Keshena, WI
- Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity - NCT00664755-29403
Conditions: Nicotine Dependence Location: Charleston, SC
- Mindfulness Training for Smoking Cessation - NCT01144689-06516
Conditions: Cigarette Smoking - Tobacco Smoking - Nicotine Dependence - Smoking Cessation Location: West Haven, CT
- Modeling Stress-precipitated Smoking Behavior for Medication Development: Guanfacine - NCT00773357-06519
Conditions: Smoking Location: New Haven, CT
- Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation - NCT01014455-55905
Conditions: Smoking Location: Rochester, MN
- Mood Management Phone Counseling in Smoking Cessation - NCT00500877-02906
Conditions: Cigarette Smoking Location: Providence, RI
- Motivation and Skills for Delta-9-Tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail - NCT00506753-02920
Conditions: Alcohol Drinking - Marijuana Smoking Location: Cranston, RI
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers - NCT00502216-06511
Conditions: Smoking - Nicotine Dependence Location: New Haven, CT
- Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment - NCT00938886-02912
Conditions: Hazardous Drinking - Cigarette Smoking Location: Providence, RI
- Natural History of Attempts to Stop Smoking - NCT00995644-05401
Conditions: Tobacco Use Cessation Location: Burlington, VT
- Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction - NCT01056926-27705
Conditions: Smoking Location: Durham, NC
- Neuroimaging Attentional Impairment During Abstinence - NCT00692406-27705
Conditions: Smoking - Non Smoking Location: Durham, NC
- Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence - NCT00672256-27705
Conditions: Smoking - ADHD Location: Durham, NC
- Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD) - NCT01123668-27705
Conditions: Smoking - ADHD Location: Durham, NC
- Nicotine Delivery Systems - NCT00108342-90073
Conditions: Smoking Location: West Los Angeles, CA
- Nicotine Patch Pretreatment for Smoking Cessation in PTSD - NCT00625131-27705
Conditions: Stress Disorders, Posttraumatic - Tobacco Use Disorder Location: Durham, NC
- p16 Methylation for Smoking Cessation - NCT01038492-27705
Conditions: Tobacco Use Disorder - Smoking Cessation - Lung Cancer Location: Durham, NC
- Parents of Asthmatics Quit Smoking - NCT00862368-02721
Conditions: Asthma - Smoking Cessation Location: Fall River, MA
- Parents of Asthmatics Quit Smoking - NCT00862368-02906
Conditions: Asthma - Smoking Cessation Location: Providence, RI
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-
Conditions: Smoking Cessation Location: Metarie, LA
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-14263
Conditions: Smoking Cessation Location: Buffalo, NY
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-21224
Conditions: Smoking Cessation Location: Baltimore, MD
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-29464
Conditions: Smoking Cessation Location: Mt Pleasant, SC
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-32806
Conditions: Smoking Cessation Location: Orlando, FL
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-33606
Conditions: Smoking Cessation Location: Tampa, FL
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-33709
Conditions: Smoking Cessation Location: St. Petersburg, FL
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-34601
Conditions: Smoking Cessation Location: Brooksville, FL
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-37203
Conditions: Smoking Cessation Location: Nashville, TN
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-45237
Conditions: Smoking Cessation Location: Cincinnati, OH
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-46202
Conditions: Smoking Cessation Location: Indianapolis, IN
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-53711
Conditions: Smoking Cessation Location: Madison, WI
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-55414
Conditions: Smoking Cessation Location: Minneapolis, MN
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-55905
Conditions: Smoking Cessation Location: Rochester, MN
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-68134
Conditions: Smoking Cessation Location: Omaha, NE
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-80204
Conditions: Smoking Cessation Location: Denver, CO
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-83704
Conditions: Smoking Cessation Location: Boise, ID
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-84020
Conditions: Smoking Cessation Location: Salt Lake City, UT
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-84107
Conditions: Smoking Cessation Location: Salt Lake City, UT
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-85724
Conditions: Smoking Cessation Location: Tucson, AZ
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-90720
Conditions: Smoking Cessation Location: Los Alamitos, CA
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-91316
Conditions: Smoking Cessation Location: Encino, CA
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-92108
Conditions: Smoking Cessation Location: San Diego, CA
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-92660
Conditions: Smoking Cessation Location: Newport Beach, CA
- Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies - NCT01178346-98104
Conditions: Smoking Cessation Location: Seattle, WA
- Pharmacogenetics of Nicotine Metabolism in African-Americans - NCT00879918-94110
Conditions: Cigarette Smoking Location: San Francisco, CA
- Pharmacogenetics, Emotional Reactivity and Smoking - NCT00507728-77030
Conditions: Tobacco Use Disorder - Smoking Cessation Location: Houston, TX
- Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence - NCT01034384-21224
Conditions: Smoking Cessation Location: Baltimore, MD
- Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy - NCT00888979-06102
Conditions: Tobacco Use Disorder Location: Hartford, CT
- Predictors of Teen Smoking-cessation - NCT01141517-43205
Conditions: Cigarette Smoking Location: Columbus, OH
- Preoperative Nicotine Lozenges - NCT00586482-85054
Conditions: Smoking Location: Scottsdale, AZ
- Preventing Postpartum Return to Smoking - NCT00917943-27705
Conditions: Smoking Location: Durham, NC
- Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers - NCT00113074-
Conditions: Cardiovascular Diseases - Heart Diseases - Hypertension Location: Iowa City, IA
- Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers - NCT00113074-55905
Conditions: Cardiovascular Diseases - Heart Diseases - Hypertension Location: Rochester, MN
- Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta - NCT00181714-02138
Conditions: ADHD Location: Cambridge, MA
- Prize Reinforcement for Smoking Cessation - NCT00865254-48207
Conditions: Nicotine Dependence Location: Detroit, MI
- Project COMBAT: Combating Tobacco Use in the United States Army - NCT00948233-76544
Conditions: Smoking - Smoking Cessation Location: Killeen, TX
- Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia - NCT00231101-19401
Conditions: Smoking Behavior in Schizophrenia Location: Norristown, PA
- Quit and Win Contests to Improve Smoking Cessation Among College Students - NCT01096108-55455
Conditions: Tobacco Use Cessation Location: Minneapolis, MN
- QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions - NCT01065493-22908
Conditions: Smoking - Tobacco Use Disorder Location: Charlottesville, VA
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-01610
Conditions: Tobacco Dependence - HIV Infections Location: Worcester, MA
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-01854
Conditions: Tobacco Dependence - HIV Infections Location: Lowell, MA
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-02129
Conditions: Tobacco Dependence - HIV Infections Location: Roxbury, MA
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-02740
Conditions: Tobacco Dependence - HIV Infections Location: New Bedford, MA
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-02903
Conditions: Tobacco Dependence - HIV Infections Location: Providence, RI
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-02906A
Conditions: Tobacco Dependence - HIV Infections Location: Providence, RI
- Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking - NCT00503230-02906B
Conditions: Tobacco Dependence - HIV Infections Location: Providence, RI
- Reducing Tobacco Related Health Disparities - NCT00984724-77030
Conditions: Smoking Cessation - Smoking Location: Houston, TX
- Relapse Prevention With Varenicline - NCT00944554-21224
Conditions: Recurrence - Smoking Cessation - Substance-Related Disorders Location: Baltimore, MD
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-06360
Conditions: Smoking Cessation - Depression Location: Norwich, CT
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-19139
Conditions: Smoking Cessation - Depression Location: Philadelphia, PA
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-32216
Conditions: Smoking Cessation - Depression Location: Jacksonville, FL
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-32547
Conditions: Smoking Cessation - Depression Location: Fort Walton Beach, FL
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-32806
Conditions: Smoking Cessation - Depression Location: Orlando, FL
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-38134
Conditions: Smoking Cessation - Depression Location: Bartlett, TN
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-44122
Conditions: Smoking Cessation - Depression Location: Beachwood, OH
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-45237
Conditions: Smoking Cessation - Depression Location: Cincinnati, OH
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-66211
Conditions: Smoking Cessation - Depression Location: Overland, KS
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-66212
Conditions: Smoking Cessation - Depression Location: Overland Park, KS
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-67207
Conditions: Smoking Cessation - Depression Location: Wichita, KS
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-77008
Conditions: Smoking Cessation - Depression Location: Houston, TX
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-78756
Conditions: Smoking Cessation - Depression Location: Austin, TX
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-80045
Conditions: Smoking Cessation - Depression Location: Aurora, CO
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-91403
Conditions: Smoking Cessation - Depression Location: Sherman Oaks, CA
- Safety and Efficacy of 12 Weeks of Varenicline for Smoking Cessation in Smokers With Depression - NCT01078298-92845
Conditions: Smoking Cessation - Depression Location: Garden Grove, CA
- Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome - NCT01170338-07112
Conditions: Smoking - Acute Coronary Syndrome Location: Newark, NJ
- Smoking Cessation and Sexual Health in Men - NCT00833404-78712
Conditions: Smoking Cessation Location: Austin, TX
- Smoking Cessation for American Indians - NCT01106456-66160
Conditions: Smoking Cessation Location: Kansas City, KS
- Smoking Cessation for American Indians - NCT01106456-73104
Conditions: Smoking Cessation Location: Oklahoma City, OK
- Smoking Cessation for Depressed Smokers - NCT00494728-77030
Conditions: Smoking - Depression Location: Houston, TX
- Smoking Cessation for Low-Income Adults - NCT00948129-77030
Conditions: Smoking Cessation - Smoking Location: Houston, TX
- Smoking Cessation for Veterans With Severe and Persistent Mental Illness - NCT00960375-21201
Conditions: Schizoaffective Disorder - Schizophrenia - Mood Disorders With Psychotic Features Location: Baltimore, MD
- Smoking Cessation for Young Adults Who Binge Drink - 1 - NCT00218452-32224A
Conditions: Adherence - Tobacco Use Cessation - Alcohol & Drug Use - Nicotine Transdermal System Location: Jacksonville, FL
- Smoking Cessation for Young Adults Who Binge Drink - 1 - NCT00218452-32224B
Conditions: Adherence - Tobacco Use Cessation - Alcohol & Drug Use - Nicotine Transdermal System Location: Jacksonville, FL
- Smoking Cessation for Young Adults Who Binge Drink - 1 - NCT00218452-55905
Conditions: Adherence - Tobacco Use Cessation - Alcohol & Drug Use - Nicotine Transdermal System Location: Rochester, MN
- Smoking Cessation in Nonunion, Malunion, Osseous Infection - NCT00754299-17033
Conditions: Fracture Nonunion - Infection Location: Hershey, PA
- Smoking Cessation in Rural Hospitals - NCT01063972-
Conditions: Smoking Cessation Location: Kansas City, KS
- Smoking Cessation Invention in the Emergency Department (ED) - NCT01173653-37232
Conditions: Smoking Cessation - Tobacco Use Cessation - Health Behavior Location: Nashville, TN
- Smoking Cessation Treatment for Head & Neck Cancer Patients - NCT01098955-77030
Conditions: Head and Neck Cancer - Smoking Cessation Location: Houston, TX
- Smoking Cessation Treatment for Head and Neck Cancer Patients - NCT00931021-06511
Conditions: Smoking Cessation Location: New Haven, CT
- Smoking Cessation Treatment for Methadone Maintenance Patients - NCT01027754-10467
Conditions: Smoking Cessation - Substance-Related Disorders Location: Bronx, NY
- Smoking Cessation Using Motivational Therapy and Varenicline - NCT00701896-43210
Conditions: Smoking - HIV Infections Location: Columbus, OH
- Smoking Interventions for Hospital Patients - NCT01177176-02114
Conditions: Cigarette Smoking Location: Boston, MA
- Smoking Study With Behavioral Therapy for Hypertensive Patients - NCT00879177-06030
Conditions: Cigarette Smoking - Hypertension Location: Farmington, CT
- Smoking Termination Enhancement Project (STEP) - NCT01065506-05405
Conditions: Smoking Location: Burlington, VT
- Smoking Termination Enhancement Project (STEP) - NCT01065506-75206
Conditions: Smoking Location: Dallas, TX
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-15213
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Pittsburgh, PA
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-29483
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Summerville, SC
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-32246
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Jacksonville, FL
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-43207
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Columbus, OH
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-85713
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Tucson, AZ
- Smoking-Cessation and Stimulant Treatment (S-CAST) - NCT01077024-97470
Conditions: Cocaine Dependence - Methamphetamine Dependence - Nicotine Dependence Location: Roseburg, OR
- Strategies to Avoid Returning to Smoking - NCT00757068-15218
Conditions: Smoking Location: Pittsburgh, PA
- Strategies to Help Adult ED Patients Quit Smoking - NCT00297466-10467
Conditions: Tobacco Use Location: Bronx, NY
- Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation - NCT00419731-55414
Conditions: Tobacco Use Disorder Location: Minneapolis, MN
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt - NCT00571805-10010
Conditions: Nicotine Dependence Location: New York, NY
- Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD) - NCT01055886-27705
Conditions: Smoking Cessation Location: Durham, NC
- Technological Innovations in Behavioral Treatments for Cigarette Smoking - NCT00926939-10010
Conditions: Cigarette Smoking Location: New York City, NY
- Technology-Enhanced Quitline Services to Prevent Smoking Relapse - NCT00888992-98104
Conditions: Smoking Cessation Location: Seattle, WA
- Telephone Care Coordination for Smokers in VA Mental Health Clinics - NCT00724308-10010
Conditions: Smoking Location: New York, NY
- The Effect of Exercise on Acute Nicotine Withdrawal - NCT01047930-15213
Conditions: Nicotine Dependence - Smoking - Sleep Disorders, Intrinsic Location: Pittsburgh, PA
- The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse - NCT00773422-06519
Conditions: Smoking Location: New Haven, CT
- The Effect of Smoking on Perception - NCT00456534-20016
Conditions: Nicotine Dependence Location: Washington, DC
- The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior - NCT00580853-06519
Conditions: Smoking Lapse Behavior Location: New Haven, CT
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|